Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
出版年份 2017 全文链接
标题
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-07
DOI
10.1038/s41598-017-00889-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
- (2016) Semir Beyaz et al. NATURE
- Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
- (2016) Manuel Vázquez-Carrera TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- The forgotten members of the glucagon family
- (2014) Dominique Bataille et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- HDL-targeted therapies: progress, failures and future
- (2014) Bronwyn A. Kingwell et al. NATURE REVIEWS DRUG DISCOVERY
- Harnessing the benefits of PPARβ/δ agonists
- (2013) Louise S. Mackenzie et al. LIFE SCIENCES
- Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol
- (2012) Eric J. Olson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
- (2012) S. Colin et al. EUROPEAN HEART JOURNAL
- Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis
- (2012) Marjan Wouthuyzen-Bakker et al. PEDIATRIC RESEARCH
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
- (2011) Mehdi Daoudi et al. GASTROENTEROLOGY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol
- (2009) François Briand et al. CTS-Clinical and Translational Science
- Scavenger Receptor BI-mediated Selective Uptake Is Required for the Remodeling of High Density Lipoprotein by Endothelial Lipase
- (2009) Niels Nijstad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
- (2009) Carlos L. J. Vrins et al. JOURNAL OF LIPID RESEARCH
- Targeted Genetic Disruption of Peroxisome Proliferator–Activated Receptor-δ and Colonic Tumorigenesis
- (2009) Xiangsheng Zuo et al. JNCI-Journal of the National Cancer Institute
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- AMPK and PPARδ Agonists Are Exercise Mimetics
- (2008) Vihang A. Narkar et al. CELL
- Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
- (2008) Jeffrey M. Peters et al. CLINICAL SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started